{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:53:03Z","timestamp":1791928383276,"version":"4.3.4"},"reference-count":136,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) represents a significant global health challenge. While two drugs (semaglutide, resmetirom) have recently been approved for nonalcoholic steatohepatitis (NASH), their clinical utility is constrained by gastrointestinal side effects, insufficient efficacy against fibrosis, and dose-related adverse events. Similarly, obeticholic acid (OCA), a farnesoid X receptor (FXR) agonist with antifibrotic potential, is associated with significant side effects, including severe pruritus. Dysregulation of bile acid (BA) metabolism is a central driver of NAFLD progression, characterized by imbalances in synthesis, impaired enterohepatic circulation, and aberrant nuclear receptor signaling. Certain hydrophobic BAs contribute to hepatocyte apoptosis, oxidative stress, and inflammation, thereby exacerbating liver injury. Targeting BA homeostasis is thus a promising therapeutic strategy, with natural products emerging as attractive candidates due to their multi-target actions and favorable safety profiles. This review summarizes 10 major classes of natural products, including traditional Chinese medicine (TCM) formulas, flavonoids, saccharides, saponins, alkaloids, curcuminoids, lignans, iridoid glycosides, sterols\/terpenoids, and phenolic acids\/other phenolics, that alleviate NAFLD by regulating BA metabolism. These agents modulate BA-sensing receptors, reshape the gut microbiota to optimize BA conversion, and regulate key BA transporters and enzymes. Compared with synthetic drugs, natural products offer broader efficacy, lower toxicity, and greater adaptability to the heterogeneity of NAFLD. However, significant limitations persist. Preclinical studies rely heavily on single-sex rodent models, while clinical evidence remains inconsistent. Crucially, mechanistic causality, such as the interplay between the gut microbiota and BAs, lacks rigorous validation through methods like fecal microbiota transplantation (FMT) or gene knockout studies. Furthermore, challenges in metabolite standardization and dose rationality hinder clinical translation. Future research must prioritize human-relevant models, large-scale randomized controlled trials (RCTs) with histological endpoints, and robust causal validation. By addressing these gaps, natural products targeting BA metabolism hold great promise to complement or replace existing therapies, offering safer and more effective personalized treatments for NAFLD.<\/jats:p>","DOI":"10.3389\/fphar.2025.1640873","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:29:08Z","timestamp":1763706548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["A critical review of natural products driven correction of bile acid dysregulation: a therapeutic strategy for nonalcoholic fatty liver disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Qing","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"28857","DOI":"10.1074\/jbc.M011610200","article-title":"Human bile salt export pump promoter is transactivated by the farnesoid X receptor\/bile acid receptor","volume":"276","author":"Ananthanarayanan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3748\/wjg.v19.i8.1158","article-title":"From fatty liver to fibrosis: a tale of \u201csecond hit\u201d","volume":"19","author":"Basaranoglu","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/cphy.c120027","article-title":"Bile formation and secretion","volume":"3","author":"Boyer","year":"2013","journal-title":"Compr. Physiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/hep.31599","article-title":"NAFLD: reporting histologic findings in clinical practice","volume":"73","author":"Brunt","year":"2021","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1517\/14728222.10.3.409","article-title":"FXR: a target for cholestatic syndromes?","volume":"10","author":"Cai","year":"2006","journal-title":"Expert Opin. Ther. Targets"},{"key":"B7","doi-asserted-by":"publisher","first-page":"112825","DOI":"10.1016\/j.biopha.2022.112825","article-title":"Jiangzhi granule attenuates non-alcoholic steatohepatitis through modulating bile acid in mice fed high-fat vitamin D deficiency diet","volume":"149","author":"Cao","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American gastroenterological association, American association for the study of liver diseases, and American college of gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/s41430-018-0386-5","article-title":"A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial","volume":"73","author":"Chashmniam","year":"2019","journal-title":"Eur. J. Clin. Nutr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/jgh.15709","article-title":"Altered bile acid glycine: taurine ratio in the progression of chronic liver disease","volume":"37","author":"Chen","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0197923","DOI":"10.1128\/spectrum.01979-23","article-title":"Ling-gui-zhu-gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota","volume":"12","author":"Chen","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11684-021-0880-3","article-title":"Lingguizhugan decoction, a Chinese herbal formula, improves insulin resistance in overweight\/obese subjects with non-alcoholic fatty liver disease: a translational approach","volume":"16","author":"Dai","year":"2022","journal-title":"Front. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.3390\/molecules29174080","article-title":"Gypensapogenin A-Liposomes efficiently ameliorates hepatocellular lipid accumulation via activation of FXR receptor","volume":"29","author":"Deng","year":"2024","journal-title":"Molecules"},{"key":"B16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"120269","DOI":"10.1016\/j.jep.2025.120269","article-title":"Huaganjian decoction ameliorates metabolic dysfunction-associated steatotic liver disease through liver-gut crosstalk","volume":"353","author":"Dong","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"112948","DOI":"10.1016\/j.fct.2022.112948","article-title":"Tectorigenin ameliorated high-fat diet-induced nonalcoholic fatty liver disease through anti-inflammation and modulating gut microbiota in mice","volume":"164","author":"Duan","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"100222","DOI":"10.1016\/j.jhepr.2020.100222","article-title":"NASH-related increases in plasma bile acid levels depend on insulin resistance","volume":"3","author":"Grzych","year":"2021","journal-title":"JHEP Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1039\/c4mb00500g","article-title":"A metabolomic and pharmacokinetic study on the mechanism underlying the lipid-lowering effect of orally administered berberine","volume":"11","author":"Gu","year":"2015","journal-title":"Mol. Biosyst."},{"key":"B22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.phrs.2017.04.021","article-title":"Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling","volume":"121","author":"Gu","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1002\/ptr.7770","article-title":"Deoxyschizandrin ameliorates obesity and non-alcoholic fatty liver disease: involvement of dual farnesyl X receptor\/G protein-coupled bile acid receptor 1 activation and leptin sensitization","volume":"37","author":"Gu","year":"2023","journal-title":"Phytother. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"8343","DOI":"10.3390\/ijms23158343","article-title":"Interactive relationships between intestinal flora and bile acids","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"108794","DOI":"10.1016\/j.cbi.2019.108794","article-title":"Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR\/LXRs-dependent manner","volume":"311","author":"Han","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"B26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/19490976.2018.1458180","article-title":"Bile acid oxidation by Eggerthella lenta strains C592 and DSM 2243(T)","volume":"9","author":"Harris","year":"2018","journal-title":"Gut Microbes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1080\/1040841X.2023.2262020","article-title":"Bile acid and its bidirectional interactions with gut microbiota: a review","volume":"50","author":"He","year":"","journal-title":"Crit. Rev. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ajcnut.2024.05.017","article-title":"Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial","volume":"120","author":"He","year":"","journal-title":"Am. J. Clin. Nutr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.3390\/nu12092598","article-title":"TGR5 signaling in hepatic metabolic health","volume":"12","author":"Holter","year":"2020","journal-title":"Nutrients"},{"key":"B31","doi-asserted-by":"publisher","first-page":"716783","DOI":"10.3389\/fnut.2021.716783","article-title":"Dietary interventions in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"8","author":"Houttu","year":"2021","journal-title":"Front. Nutr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"157172","DOI":"10.1016\/j.phymed.2025.157172","article-title":"Celastrol ameliorates metabolic dysfunction associated steatohepatitis by regulating the CYP7B1-mediated alternative bile acid synthetic pathway","volume":"147","author":"Hu","year":"2025","journal-title":"Phytomedicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1039\/c9fo00263d","article-title":"A sulfated polysaccharide from Gracilaria Lemaneiformis regulates cholesterol and bile acid metabolism in high-fat diet mice","volume":"10","author":"Huang","year":"2019","journal-title":"Food Funct."},{"key":"B34","doi-asserted-by":"publisher","first-page":"155919","DOI":"10.1016\/j.phymed.2024.155919","article-title":"Yellow tea polysaccharides protect against non-alcoholic fatty liver disease via regulation of gut microbiota and bile acid metabolism in mice","volume":"133","author":"Huang","year":"2024","journal-title":"Phytomedicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1002\/cphy.c210024","article-title":"Bile acids, gut microbiome and the road to fatty liver disease","volume":"12","author":"Hylemon","year":"2021","journal-title":"Compr. Physiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/CM9.0000000000002156","article-title":"Bile acids and sphingolipids in non-alcoholic fatty liver disease","volume":"135","author":"Jackson","year":"2022","journal-title":"Chin. Med. J. Engl."},{"key":"B38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/HEP.0000000000000670","article-title":"Metabolic dysfunction-associated steatotic liver disease: update and impact of new nomenclature on the American association for the study of liver diseases practice guidance on nonalcoholic fatty liver disease","volume":"79","author":"Kanwal","year":"2024","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor","volume":"277","author":"Kast","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/s0005-2736(99)00169-8","article-title":"Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance","volume":"1461","author":"K\u00f6nig","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2024.3.06","article-title":"Does berberine impact anthropometric, hepatic, and metabolic parameters in patients with metabolic dysfunction-associated fatty liver disease? Randomized, double-blind placebo-controlled trial","volume":"75","author":"Koperska","year":"2024","journal-title":"J. Physiol. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.3390\/foods13193076","article-title":"Isorhamnetin in quinoa whole-grain flavonoids intervenes in non-alcoholic fatty liver disease by modulating bile acid metabolism through regulation of FXR expression","volume":"13","author":"La","year":"2024","journal-title":"Foods"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/biom13091356","article-title":"Alterations in circulating bile acids in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis","volume":"13","author":"Lai","year":"2023","journal-title":"Biomolecules"},{"key":"B47","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"B48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.21037\/hbsn.2019.09.03","article-title":"Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease","volume":"9","author":"Li","year":"2020","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1511885","DOI":"10.3389\/fmicb.2025.1511885","article-title":"Xiaohua funing decoction ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and bile acids","volume":"16","author":"Li","year":"2025","journal-title":"Front. Microbiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11655-010-0023-1","article-title":"Treatment of non-alcoholic fatty liver disease by qianggan capsule","volume":"16","author":"Li","year":"2010","journal-title":"Chin. J. Integr. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"112896","DOI":"10.1016\/j.jep.2020.112896","article-title":"Qiang-gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice","volume":"258","author":"Li","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/hepr.13444","article-title":"Changes of gut microbiota during silybin-mediated treatment of high-fat diet-induced non-alcoholic fatty liver disease in mice","volume":"50","author":"Li","year":"","journal-title":"Hepatol. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"109915","DOI":"10.1016\/j.biopha.2020.109915","article-title":"Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis","volume":"124","author":"Li","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"115333","DOI":"10.1016\/j.jep.2022.115333","article-title":"Penthorum chinense pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice","volume":"294","author":"Li","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e202200146","DOI":"10.1002\/cbdv.202200146","article-title":"Dihydroflavonoids as bioactive components of Penthorum chinense, a miao ethnomedicine, against NAFLD through bile acid metabolism pathway","volume":"19","author":"Li","year":"","journal-title":"Chem. Biodivers."},{"key":"B56","doi-asserted-by":"publisher","first-page":"833414","DOI":"10.3389\/fphar.2022.833414","article-title":"Medicinal formula huazhi-rougan attenuates non-alcoholic steatohepatitis through enhancing fecal bile acid excretion in mice","volume":"13","author":"Li","year":"","journal-title":"Front. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"925349","DOI":"10.3389\/fphar.2022.925349","article-title":"Multi-omics reveals inhibitory effect of baicalein on non-alcoholic fatty liver disease in mice","volume":"13","author":"Li","year":"","journal-title":"Front. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3390\/foods12081617","article-title":"Lycium barbarum oligosaccharides alleviate hepatic steatosis by modulating gut microbiota in C57BL\/6J mice fed a high-fat diet","volume":"12","author":"Li","year":"2023","journal-title":"Foods"},{"key":"B59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.ajcnut.2024.07.013","article-title":"Quercetin intervention reduced hepatic fat deposition in patients with nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled crossover clinical trial","volume":"120","author":"Li","year":"","journal-title":"Am. J. Clin. Nutr."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.26599\/fshw.2022.9250218","article-title":"Saikosaponin D improves non-alcoholic fatty liver disease via gut microbiota-bile acid metabolism pathway","volume":"13","author":"Li","year":"","journal-title":"Food Sci. Hum. Wellness"},{"key":"B61","doi-asserted-by":"publisher","first-page":"118526","DOI":"10.1016\/j.jep.2024.118526","article-title":"Integrated serum metabolomics, 16S rRNA sequencing and bile acid profiling to reveal the potential mechanism of gentiopicroside against nonalcoholic steatohepatitis in lean mice","volume":"334","author":"Li","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"26130","DOI":"10.1021\/acs.jafc.5c09242","article-title":"Stachyose attenuates hepatic cholesterol deposition in nonalcoholic fatty liver mice via gut microbiota-driven bile acid profile remodeling","volume":"73","author":"Li","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"11664","DOI":"10.1039\/d2fo01167k","article-title":"Highland barley \u03b2-glucan alleviated Western diet-induced non-alcoholic fatty liver disease via increasing energy expenditure and regulating bile acid metabolism in mice","volume":"13","author":"Liu","year":"2022","journal-title":"Food Funct."},{"key":"B64","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/s1097-2765(00)00050-2","article-title":"Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors","volume":"6","author":"Lu","year":"2000","journal-title":"Mol. Cell."},{"key":"B65","doi-asserted-by":"publisher","first-page":"946360","DOI":"10.3389\/fphar.2022.946360","article-title":"Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/09637486.2024.2435849","article-title":"Ellagic acid alleviates high-fructose diet-induced non-alcoholic fatty liver disease by modulating liver metabolic profiles and gut microbiota","volume":"76","author":"Luo","year":"2025","journal-title":"Int. J. Food Sci. Nutr."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2174\/0113862073379080250701164923","article-title":"Gan-jiang-Ling-Zhu decoction prevents Paigen's diet-induced lean metabolic dysfunction-associated steatotic liver disease by regulating bile acid metabolism","volume":"28","author":"Ma","year":"2025","journal-title":"Comb. Chem. High. Throughput Screen"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1017\/S0007114521002610","article-title":"Dietary raffinose ameliorates hepatic lipid accumulation induced by cholic acid via modulation of enterohepatic bile acid circulation in rats","volume":"127","author":"Maegawa","year":"2022","journal-title":"Br. J. Nutr."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"B70","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1389200216666151103115454","article-title":"Bile acids in physiology, pathology and pharmacology","volume":"17","author":"Marin","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"B71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","article-title":"FXR signaling in the enterohepatic system","volume":"368","author":"Matsubara","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev.physiol.64.082201.100300","article-title":"Bile salt transporters","volume":"64","author":"Meier","year":"2002","journal-title":"Annu. Rev. Physiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12906-025-04759-4","article-title":"A randomized double-blind clinical trial investigating the effects of ellagic acid on glycemic status, liver enzymes, and oxidative stress in patients with non-alcoholic fatty liver disease","volume":"25","author":"Mighani","year":"2025","journal-title":"BMC Complement. Med. Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1039\/c6cp07553c","article-title":"Kinetics of the reversible inclusion of flavopereirine in cucurbit[7]uril","volume":"19","author":"Miskolczy","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.cell.2024.02.019","article-title":"The underappreciated diversity of bile acid modifications","volume":"187","author":"Mohanty","year":"2024","journal-title":"Cell"},{"key":"B76","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5009\/gnl20127","article-title":"Recent epidemiology of nonalcoholic fatty liver disease","volume":"15","author":"Murag","year":"2021","journal-title":"Gut Liver"},{"key":"B77","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/HEP.0000000000000937","article-title":"Effect of phospholipid curcumin meriva on liver histology and kidney disease in nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled trial","volume":"81","author":"Musso","year":"2025","journal-title":"Hepatology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/s0022-2275(20)41693-1","article-title":"Cholesterol 7 alpha-hydroxylase","volume":"18","author":"Myant","year":"1977","journal-title":"J. Lipid Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1053\/j.gastro.2020.01.051","article-title":"Therapeutic landscape for NAFLD in 2020","volume":"158","author":"Neuschwander-Tetri","year":"2020","journal-title":"Gastroenterology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e114393","DOI":"10.1371\/journal.pone.0114393","article-title":"Impact of global Fxr deficiency on experimental acute pancreatitis and genetic variation in the FXR locus in human acute pancreatitis","volume":"9","author":"Nijmeijer","year":"2014","journal-title":"PLoS One"},{"key":"B81","doi-asserted-by":"publisher","first-page":"154457","DOI":"10.1016\/j.metabol.2020.154457","article-title":"Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression","volume":"116","author":"Nimer","year":"2021","journal-title":"Metabolism"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1172\/JCI119355","article-title":"Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2)","volume":"99","author":"Oelkers","year":"1997","journal-title":"J. Clin. Invest"},{"key":"B84","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/ijms26030895","article-title":"Tetrahydrocurcumin alleviates metabolic dysfunction-associated steatohepatitis in mice by regulating serum lipids, bile acids, and gut microbiota","volume":"26","author":"Peng","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B85","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2018","journal-title":"Hepatology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"141151","DOI":"10.1016\/j.ijbiomac.2025.141151","article-title":"Metabolic restoration: rhubarb polysaccharides as a shield against non-alcoholic fatty liver disease","volume":"305","author":"Qiu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1073\/pnas.0712328105","article-title":"The organic solute transporter alpha-beta, ostalpha-ostbeta, is essential for intestinal bile acid transport and homeostasis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B88","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jhep.2022.10.023","article-title":"Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH","volume":"78","author":"Ratziu","year":"2023","journal-title":"J. Hepatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","article-title":"The role of bile acids in carcinogenesis","volume":"79","author":"Re\u017een","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41591-022-02200-8","article-title":"Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a\/b trial","volume":"29","author":"Sanyal","year":"2023","journal-title":"Nat. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"118700","DOI":"10.1016\/j.jep.2024.118700","article-title":"Zexie-baizhu decoction ameliorates non-alcoholic fatty liver disease through gut-adipose tissue crosstalk","volume":"337","author":"Shi","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"114664","DOI":"10.1016\/j.taap.2019.114664","article-title":"Altered bile acid composition and disposition in a mouse model of non-alcoholic steatohepatitis","volume":"379","author":"Suga","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"12014","DOI":"10.1021\/acs.jafc.2c04817","article-title":"Nuciferine protects against high-fat diet-induced hepatic steatosis via modulation of gut microbiota and bile acid metabolism in rats","volume":"70","author":"Sun","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"B95","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3164\/jcbn.18-116","article-title":"Green tea polyphenol (epigallocatechin-3-gallate) improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice","volume":"65","author":"Ushiroda","year":"2019","journal-title":"J. Clin. Biochem. Nutr."},{"key":"B98","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bbadis.2017.10.002","article-title":"n-3 fatty acids combined with flavan-3-ols prevent steatosis and liver injury in a murine model of NAFLD","volume":"1864","author":"Vauzour","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.cgh.2017.04.016","article-title":"A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis","volume":"15","author":"Wah Kheong","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jare.2021.06.001","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism","volume":"34","author":"Wang","year":"","journal-title":"J. Adv. Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/cells10020210","article-title":"Berberine prevents disease progression of nonalcoholic steatohepatitis through modulating multiple pathways","volume":"10","author":"Wang","year":"","journal-title":"Cells"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1257158","DOI":"10.3389\/fnut.2023.1257158","article-title":"Beneficial effects of silibinin on serum lipids, bile acids, and gut microbiota in methionine-choline-deficient diet-induced mice","volume":"10","author":"Wang","year":"2023","journal-title":"Front. Nutr."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1426049","DOI":"10.3389\/fphar.2024.1426049","article-title":"Lingguizhugan oral solution alleviates MASLD by regulating bile acids metabolism and the gut microbiota through activating FXR\/TGR5 signaling pathways","volume":"15","author":"Wang","year":"","journal-title":"Front. Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"113035","DOI":"10.1016\/j.intimp.2024.113035","article-title":"Novel insights into the role of quercetin and kaempferol from Carthamus tinctorius L. in the management of nonalcoholic fatty liver disease via NR1H4-mediated pathways","volume":"143","author":"Wang","year":"","journal-title":"Int. Immunopharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"111036","DOI":"10.1016\/j.biopha.2020.111036","article-title":"The gut microbiome-bile acid axis in hepatocarcinogenesis","volume":"133","author":"Wu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B106","doi-asserted-by":"publisher","first-page":"12093","DOI":"10.3390\/ijerph191912093","article-title":"Lycium barbarum polysaccharide regulates the lipid metabolism and alters gut microbiota in high-fat diet induced Obese mice","volume":"19","author":"Xia","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.tjnut.2023.05.026","article-title":"Stigmasterol protects against steatohepatitis induced by high-fat and high-cholesterol diet in mice by enhancing the alternative bile acid synthesis pathway","volume":"153","author":"Xin","year":"2023","journal-title":"J. Nutr."},{"key":"B108","doi-asserted-by":"publisher","first-page":"e2100067","DOI":"10.1002\/mnfr.202100067","article-title":"Soyasaponin A(2) alleviates steatohepatitis possibly through regulating bile acids and gut microbiota in the methionine and choline-deficient (MCD) diet-induced nonalcoholic steatohepatitis (NASH) mice","volume":"65","author":"Xiong","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3389\/fphar.2018.01115","article-title":"Baicalein enhances the oral bioavailability and hepatoprotective effects of silybin through the inhibition of efflux transporters BCRP and MRP2","volume":"9","author":"Xu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"29033","DOI":"10.1021\/acsomega.3c01955","article-title":"Zhuyu pill alleviates nonalcoholic fatty liver disease by regulating bile acid metabolism through the gut-liver axis","volume":"8","author":"Xu","year":"2023","journal-title":"ACS Omega"},{"key":"B111","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3390\/molecules29050976","article-title":"Involvement of bile acid metabolism and gut microbiota in the amelioration of experimental metabolism-associated fatty liver disease by nobiletin","volume":"29","author":"Xu","year":"2024","journal-title":"Molecules"},{"key":"B112","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.3390\/cells10112806","article-title":"Bile acid receptors and the gut-liver axis in nonalcoholic fatty liver disease","volume":"10","author":"Xue","year":"2021","journal-title":"Cells"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e0134172","DOI":"10.1371\/journal.pone.0134172","article-title":"Efficacy of berberine in patients with non-alcoholic fatty liver disease","volume":"10","author":"Yan","year":"2015","journal-title":"PLoS One"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1124\/dmd.118.082008","article-title":"Glycyrrhizin alleviates nonalcoholic steatohepatitis via modulating bile acids and meta-inflammation","volume":"46","author":"Yan","year":"","journal-title":"Drug Metab. Dispos."},{"key":"B115","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.biopha.2018.05.135","article-title":"Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice","volume":"105","author":"Yan","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B116","doi-asserted-by":"publisher","first-page":"106621","DOI":"10.1016\/j.phrs.2022.106621","article-title":"Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation","volume":"187","author":"Yan","year":"2023","journal-title":"Pharmacol. Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"155299","DOI":"10.1016\/j.phymed.2023.155299","article-title":"Diosgenin as a substitute for cholesterol alleviates NAFLD by affecting CYP7A1 and NPC1L1-related pathway","volume":"125","author":"Yan","year":"2024","journal-title":"Phytomedicine"},{"key":"B118","doi-asserted-by":"publisher","first-page":"119801","DOI":"10.1016\/j.jep.2025.119801","article-title":"Schisandra chinensis lignans ameliorate hepatic inflammation and steatosis in methionine choline-deficient diet-fed mice by modulating the gut-liver axis","volume":"348","author":"Yan","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.3390\/foods12132492","article-title":"Ginsenoside Rh4 improves hepatic lipid metabolism and inflammation in a model of NAFLD by targeting the gut liver axis and modulating the FXR signaling pathway","volume":"12","author":"Yang","year":"2023","journal-title":"Foods"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e70203","DOI":"10.1096\/fj.202402102R","article-title":"Liver-gut axis signaling regulates circadian energy metabolism in shift workers","volume":"38","author":"Yang","year":"","journal-title":"Faseb J."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.clnu.2024.06.018","article-title":"Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of dipeptide kinase 4","volume":"43","author":"Yang","year":"","journal-title":"Clin. Nutr."},{"key":"B122","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"154444","DOI":"10.1016\/j.phymed.2022.154444","article-title":"Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling","volume":"107","author":"Zhai","year":"2022","journal-title":"Phytomedicine"},{"key":"B125","doi-asserted-by":"publisher","first-page":"15203","DOI":"10.1038\/s41598-023-42358-w","article-title":"Honokiol affects the composition of gut microbiota and the metabolism of lipid and bile acid in methionine-choline deficiency diet-induced NASH mice","volume":"13","author":"Zhai","year":"2023","journal-title":"Sci. Rep."},{"key":"B126","doi-asserted-by":"publisher","first-page":"850777","DOI":"10.3389\/fphar.2022.850777","article-title":"Natural phenylethanoid supplementation alleviates metabolic syndrome in female mice induced by high-fructose diet","volume":"13","author":"Zhan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"13452","DOI":"10.1021\/acs.jmedchem.2c01394","article-title":"Discovery of betulinic acid derivatives as potent intestinal farnesoid X receptor antagonists to ameliorate nonalcoholic steatohepatitis","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"7723","DOI":"10.1021\/acs.jafc.3c00952","article-title":"Dietary isoquercetin reduces hepatic cholesterol and triglyceride in NAFLD mice by modulating bile acid metabolism via intestinal FXR-FGF15 signaling","volume":"71","author":"Zhang","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"B129","doi-asserted-by":"publisher","first-page":"45447","DOI":"10.1021\/acsomega.4c07463","article-title":"Qinlian hongqu decoction modulates FXR\/TGR5\/GLP-1 pathway to improve insulin resistance in NAFLD mice: bioinformatics and experimental study","volume":"9","author":"Zhang","year":"","journal-title":"ACS Omega"},{"key":"B130","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/jpp\/rgae014","article-title":"Integration of pharmacodynamics and metabolomics to reveal rhubarb anthraquinone protection against nonalcoholic fatty liver disease rat model","volume":"76","author":"Zhang","year":"","journal-title":"J. Pharm. Pharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"142276","DOI":"10.1016\/j.ijbiomac.2025.142276","article-title":"Salidroside attenuates NASH through regulating bile acid-FXR\/TGR5 signaling pathway via targeting gut microbiota","volume":"307","author":"Zhang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"771976","DOI":"10.3389\/fphar.2021.771976","article-title":"Ilexsaponin A(1) ameliorates diet-induced nonalcoholic fatty liver disease by regulating bile acid metabolism in mice","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"117401","DOI":"10.1016\/j.jep.2023.117401","article-title":"Astragalus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice","volume":"320","author":"Zheng","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1002\/ptr.8474","article-title":"Gut microbiota and bile acid metabolism in the mechanism of ginsenoside re against nonalcoholic fatty liver disease","volume":"39","author":"Zheng","year":"2025","journal-title":"Phytother. Res."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1159\/000493297","article-title":"Ganoderma lucidum polysaccharide peptide alleviates hepatoteatosis via modulating bile acid metabolism dependent on FXR-SHP\/FGF","volume":"49","author":"Zhong","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B136","doi-asserted-by":"publisher","first-page":"854790","DOI":"10.3389\/fphar.2022.854790","article-title":"Diosgenin ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and related lipid\/amino acid metabolism in high fat diet-fed rats","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1640873\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:29:11Z","timestamp":1763706551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1640873\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":136,"alternative-id":["10.3389\/fphar.2025.1640873"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1640873","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"article-number":"1640873"}}